Heterozygous deletion of occurs in del(5q) MDS and has been connected to damaged erythropoiesis, quality of this disease subtype. called the 5q- symptoms that is certainly characterized by a serious macrocytic anemia, a regular or raised platelet count number with hypolobated micromegakaryocytes and a low price of development to severe myelogenous leukemia1C3. The serious macrocytic anemia in del(5q) MDS sufferers provides been connected to haploinsufficiency of the ribosomal proteins little subunit 14 (RPS14)4. In a display screen of the 5q33 common Cdkn1b removed area linked with the 5q- symptoms, just shRNAs concentrating on the gene triggered a serious mass in erythroid difference, while compelled overexpression of in cells from MDS sufferers with the 5q removal rescued erythropoeisis4. Germline, heterozygous inactivating mutations or deletions of and various other ribosomal 1007207-67-1 manufacture proteins genetics trigger Diamond-Blackfan anemia (DBA), a disorder that, like del(5q) MDS, is certainly characterized by macrocytic anemia5C9. Decreased phrase of specific ribosomal protein, including RPS14 and RPS19, boosts g53 amounts and g53 focus on gene manifestation in cell lines, main human being hematopoietic progenitor cells, and individual examples10C12. Pharmacologic or hereditary inactivation of g53 rescues the difference problem of progenitor cells in multiple model systems7,8,10, 13. Many versions 1007207-67-1 manufacture of ribosome disorder possess been explained14. A murine model with hematopoietic-specific heterozygous removal of recapitulated the erythroid phenotype of del(5q) MDS and DBA that is usually rescued by g53 inactivation, though inactivation offers not really been explained in 1007207-67-1 manufacture either DBA or MDS7,8,15. To model del(5q) MDS, a mouse was produced wherein a series of DNA sections syntenic to the generally erased area on human being chromosome 5, including and 7 additional genetics. In purchase to investigate the hematologic phenotype and molecular effects particular to haploinsufficiency inactivation. Outcomes haploinsufficiency induce a g53-reliant erythroid difference problem in late-stage erythroblasts We produced a conditional knockout model in which exons 2C4 are flanked by loxP sites (Suppl. Fig. 1a). Pursuing passes across to transgenic rodents, we caused excision in hematopoietic cells by poly(I:C) treatment and verified haploinsufficient manifestation of (Suppl. Fig. 1b, c). Rodents with haploinsufficiency in hematopoietic cells created a intensifying anemia (Fig. 1a; Suppl. Fig. 1d, at the). At around 550 times of age group, the reticulocyte count number of haploinsufficient rodents reduced precipitously and was connected with loss of life in a subset of rodents (Fig. 1a, w). Physique 1 haploinsufficiency outcomes in a g53-mediated erythroid difference problem We following decided whether haploinsufficiency causes a under the radar, stage-specific problem in erythroid advancement. We characterized the phases of erythropoiesis by circulation cytometry on the basis of Ter119 and Compact disc71 manifestation (Supplementary Fig. 1d). haploinsufficient rodents experienced reduced erythropoiesis at the changeover from Compact disc71+Ter119+ basophilic and early chromatophilic erythroblasts (RII) to Compact 1007207-67-1 manufacture disc71intermediate/lowTer119+ poly/orthochromatophilic erythroblasts and enucleated erythrocytes (RIII/RIV), (Fig. 1c). haploinsufficient rodents experienced significant splenomegaly with dominance of the white pulp credited to an growth of the early erythroid area (Fig. 1d; Suppl. Fig. 1i). Younger rodents, 22 weeks after excision, also experienced reduced difference at the RIII/4 changeover (g<0.001) with a lower in quiescence of cells in the RI populace (g>0.001); (Suppl. Fig. 1f, g), collectively recommending that more youthful haploinsufficient rodents induce compensatory boost in erythropiesis leading to a hold off in advancement of serious anemia. To determine whether the anemia is certainly powered by haploinsufficiency in hematopoietic cells but not really in the bone fragments marrow stroma, we produced blended bone fragments marrow chimeras (Suppl. Fig. 1h). Wild-type rodents transplanted with haploinsufficient hematopoietic cells created anemia with kinetics equivalent to untransplanted rodents, credit reporting that the phenotype.
Posted in Melastatin Receptors
The provided text passage is a scientific research article excerpt that discusses the genetic and molecular mechanisms underlying a specific type of myelodysplastic syndrome (MDS) characterized by a deletion on chromosome 5 (del(5q) MDS). It describes the role of the RPS14 gene and the p53 pathway in the pathogenesis of this condition.
no_question

the passage does not contain any mathematical questions or answers. it is primarily focused on describing the biological mechanisms and experimental findings related to del(5q) mds.
Given a text passage, determine:
    1. If it contains a mathematical question (including word problems or calculations)
    2. If an answer to that mathematical question is provided in the text

First, describe the content structure you found in 1-2 sentences.

Then provide your analysis in the following format:
TYPE: <one of the following values>
- NO_QUESTION
- SINGLE_QUESTION
- SINGLE_QUESTION_WITH_ANSWER
- MULTIPLE_QUESTIONS
- MULTIPLE_QUESTIONS_WITH_ANSWERS
system
Heterozygous deletion of occurs in del(5q) MDS and has been connected to damaged erythropoiesis, quality of this disease subtype. called the 5q- symptoms that is certainly characterized by a serious macrocytic anemia, a regular or raised platelet count number with hypolobated micromegakaryocytes and a low price of development to severe myelogenous leukemia1C3. The serious macrocytic anemia in del(5q) MDS sufferers provides been connected to haploinsufficiency of the ribosomal proteins little subunit 14 (RPS14)4. In a display screen of the 5q33 common Cdkn1b removed area linked with the 5q- symptoms, just shRNAs concentrating on the gene triggered a serious mass in erythroid difference, while compelled overexpression of in cells from MDS sufferers with the 5q removal rescued erythropoeisis4. Germline, heterozygous inactivating mutations or deletions of and various other ribosomal 1007207-67-1 manufacture proteins genetics trigger Diamond-Blackfan anemia (DBA), a disorder that, like del(5q) MDS, is certainly characterized by macrocytic anemia5C9. Decreased phrase of specific ribosomal protein, including RPS14 and RPS19, boosts g53 amounts and g53 focus on gene manifestation in cell lines, main human being hematopoietic progenitor cells, and individual examples10C12. Pharmacologic or hereditary inactivation of g53 rescues the difference problem of progenitor cells in multiple model systems7,8,10, 13. Many versions 1007207-67-1 manufacture of ribosome disorder possess been explained14. A murine model with hematopoietic-specific heterozygous removal of recapitulated the erythroid phenotype of del(5q) MDS and DBA that is usually rescued by g53 inactivation, though inactivation offers not really been explained in 1007207-67-1 manufacture either DBA or MDS7,8,15. To model del(5q) MDS, a mouse was produced wherein a series of DNA sections syntenic to the generally erased area on human being chromosome 5, including and 7 additional genetics. In purchase to investigate the hematologic phenotype and molecular effects particular to haploinsufficiency inactivation. Outcomes haploinsufficiency induce a g53-reliant erythroid difference problem in late-stage erythroblasts We produced a conditional knockout model in which exons 2C4 are flanked by loxP sites (Suppl. Fig. 1a). Pursuing passes across to transgenic rodents, we caused excision in hematopoietic cells by poly(I:C) treatment and verified haploinsufficient manifestation of (Suppl. Fig. 1b, c). Rodents with haploinsufficiency in hematopoietic cells created a intensifying anemia (Fig. 1a; Suppl. Fig. 1d, at the). At around 550 times of age group, the reticulocyte count number of haploinsufficient rodents reduced precipitously and was connected with loss of life in a subset of rodents (Fig. 1a, w). Physique 1 haploinsufficiency outcomes in a g53-mediated erythroid difference problem We following decided whether haploinsufficiency causes a under the radar, stage-specific problem in erythroid advancement. We characterized the phases of erythropoiesis by circulation cytometry on the basis of Ter119 and Compact disc71 manifestation (Supplementary Fig. 1d). haploinsufficient rodents experienced reduced erythropoiesis at the changeover from Compact disc71+Ter119+ basophilic and early chromatophilic erythroblasts (RII) to Compact 1007207-67-1 manufacture disc71intermediate/lowTer119+ poly/orthochromatophilic erythroblasts and enucleated erythrocytes (RIII/RIV), (Fig. 1c). haploinsufficient rodents experienced significant splenomegaly with dominance of the white pulp credited to an growth of the early erythroid area (Fig. 1d; Suppl. Fig. 1i). Younger rodents, 22 weeks after excision, also experienced reduced difference at the RIII/4 changeover (g<0.001) with a lower in quiescence of cells in the RI populace (g>0.001); (Suppl. Fig. 1f, g), collectively recommending that more youthful haploinsufficient rodents induce compensatory boost in erythropiesis leading to a hold off in advancement of serious anemia. To determine whether the anemia is certainly powered by haploinsufficiency in hematopoietic cells but not really in the bone fragments marrow stroma, we produced blended bone fragments marrow chimeras (Suppl. Fig. 1h). Wild-type rodents transplanted with haploinsufficient hematopoietic cells created anemia with kinetics equivalent to untransplanted rodents, credit reporting that the phenotype.
Posted in Melastatin Receptors
user
The provided text passage is a scientific research article excerpt that discusses the genetic and molecular mechanisms underlying a specific type of myelodysplastic syndrome (MDS) characterized by a deletion on chromosome 5 (del(5q) MDS). It describes the role of the RPS14 gene and the p53 pathway in the pathogenesis of this condition.

TYPE: NO_QUESTION

The passage does not contain any mathematical questions or answers. It is primarily focused on describing the biological mechanisms and experimental findings related to del(5q) MDS.